(Total Views: 524)
Posted On: 06/14/2022 8:29:27 AM
Post# of 155704
Exactly Figgs,
Who do you think is behind the seeking Alpha hit piece?
Who pays seeking Alpha for each click?
Big Pharma, Big Money, Big Media.
Why all the effort focused against this monoclonal antibody?
Because this monoclonal antibody is proving unequivocally that it does single-handedly, what others treatments of all kinds fail to do despite their billions in research in myriads of mono & combo trials, both with & without other failed treatments which only result in more failed results not even half as good as what this monoclonal antibody does as a matter of course.
Leronlimab will unequivocally prove itself with the help of one faithful partner with pockets deep enough to put it through a well constructed, well thought out and well executed Phase 3 trial.
Who do you think is behind the seeking Alpha hit piece?
Who pays seeking Alpha for each click?
Big Pharma, Big Money, Big Media.
Why all the effort focused against this monoclonal antibody?
Because this monoclonal antibody is proving unequivocally that it does single-handedly, what others treatments of all kinds fail to do despite their billions in research in myriads of mono & combo trials, both with & without other failed treatments which only result in more failed results not even half as good as what this monoclonal antibody does as a matter of course.
Leronlimab will unequivocally prove itself with the help of one faithful partner with pockets deep enough to put it through a well constructed, well thought out and well executed Phase 3 trial.
(6)
(0)
